Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
16%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
PPH
27
HOLDINGS
57%
ALSO IN XPH
XPH
55
HOLDINGS
26%
ALSO IN PPH
SECTOR DRIFT (PPH minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 9.7% | 2.4% | 2.4% |
|
BRISTOL-MYERS SQUIBB CO | 4.9% | 2.3% | 2.3% |
|
JOHNSON & JOHNSON | 4.8% | 2.2% | 2.2% |
|
ZOETIS INC | 3.4% | 2.1% | 2.1% |
|
PFIZER INC | 4.8% | 2.0% | 2.0% |
PPH Overweight Relative to XPH
|
ELI LILLY & CO | 16.9% |
 |
NOVARTIS AG-ADR | 11.4% |
|
MERCK & CO. INC. | 7.3% |
 |
GLAXOSMITHKLINE PLC-SPON ADR | 4.9% |
|
MCKESSON CORP | 4.9% |
 |
NOVO-NORDISK A/S-SPONS ADR | 4.4% |
|
ABBVIE INC | 4.1% |
|
CENCORA INC | 4.0% |
 |
SANOFI-AVENTIS-ADR | 4.0% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 2.9% |
PPH Underweight Relative to XPH
|
DEFINIUM THERAPEUTICS INC | -2.6% |
|
EDGEWISE THERAPEUTICS, INC. | -2.4% |
|
PHIBRO ANIMAL HEALTH CORP-A | -2.4% |
|
ROYALTY PHARMA PLC CLASS A | -2.2% |
|
SUPERNUS PHARMACEUTICALS INC | -2.2% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.1% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | -2.1% |
|
PRESTIGE BRANDS HOLDINGS INC | -2.1% |
|
ENLIVEN THERAPEUTICS, INC. | -2.1% |
|
INNOVIVA, INC. | -2.1% |